Core Laboratories N.V. (CLB): Price and Financial Metrics

Core Laboratories N.V. (CLB)

Today's Latest Price: $24.09 USD

0.39 (-1.59%)

Updated Nov 27 5:00pm

Add CLB to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 60 in Energy - Services

See all "A" rated Strong Buy stocks

CLB Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for CLB is 7.84 -- better than 95.92% of US stocks.
  • Of note is the ratio of Core Laboratories N V's sales and general administrative expense to its total operating expenses; only 11.91% of US stocks have a lower such ratio.
  • In terms of twelve month growth in earnings before interest and taxes, Core Laboratories N V is reporting a growth rate of -178.09%; that's higher than only 11.04% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Core Laboratories N V are GDP, ARCH, LBRT, RNGR, and AG.
  • CLB's SEC filings can be seen here. And to visit Core Laboratories N V's official web site, go to

CLB Stock Price Chart Interactive Chart >

Price chart for CLB

CLB Price/Volume Stats

Current price $24.09 52-week high $48.40
Prev. close $24.48 52-week low $6.68
Day low $23.88 Volume 199,274
Day high $24.35 Avg. volume 1,053,660
50-day MA $17.00 Dividend yield 0.17%
200-day MA $18.89 Market Cap 1.07B

Core Laboratories N.V. (CLB) Company Bio

Core Laboratories provides proprietary and patented reservoir description, production enhancement, and reservoir management services used to optimize petroleum reservoir performance. The company was founded in 1936 and is based in Amsterdam, the Netherlands.

CLB Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$24.09$2.98 -85%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Core Laboratories N V. To summarize, we found that Core Laboratories N V ranked in the 13th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. In terms of the factors that were most noteworthy in this DCF analysis for CLB, they are:

  • The company's compound free cash flow growth rate over the past 5.68 years comes in at -0.19%; that's greater than only 8.34% of US stocks we're applying DCF forecasting to.
  • Core Laboratories N V's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -5.27. This coverage rate is greater than that of merely 12.16% of stocks we're observing for the purpose of forecasting via discounted cash flows.
  • Relative to other stocks in its sector (Energy), Core Laboratories N V has a reliance on debt greater than merely 20.67% of them.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

CLMT, FET, SDPI, SLB, and VTNR can be thought of as valuation peers to CLB, in the sense that they are in the Energy sector and have a similar price forecast based on DCF valuation.

CLB Latest News Stream

Event/Time News Detail
Loading, please wait...

CLB Latest Social Stream

Loading social stream, please wait...

View Full CLB Social Stream

Latest CLB News From Around the Web

Below are the latest news stories about Core Laboratories N V that investors may wish to consider to help them evaluate CLB as an investment opportunity.

Core Laboratories: The Upside Is Likely Priced In

Source: Core Laboratories COVID-19 has caused businesses to be shut down and millions of workers to become displaced. The decline in business activity has led to demand destruction in several industries, including oil. Brent oil is now in the $45 range after free-falling in March. Until the economy fully reopens,...

Shock Exchange on Seeking Alpha | August 18, 2020

Core Laboratories NV (CLB) CEO Lawrence Bruno on Q2 2020 Results - Earnings Call Transcript

Core Laboratories NV (CLB) Q2 2020 Earnings Conference Call July 23, 2020, 08:30 ET Company Participants Lawrence Bruno - Chairman, CEO, President & COO Gwendolyn Schreffler - SVP, Corporate Development & IR Christopher Hill - SVP & CFO Conference Call Participants Scott Gruber - Citigroup Sean Meakim - JPMorgan Chase...

SA Transcripts on Seeking Alpha | July 23, 2020

Core Laboratories (CLB) Q2 2020 Earnings Call Transcript

CLB earnings call for the period ending June 30, 2020.

Yahoo | July 23, 2020

Core Labs' (CLB) Q2 Earnings and Sales Surpass Estimates

In the June quarter, Core Labs (CLB) generates $27 million in operating cash and its capital expenditure totals $3.1 million, leading to $23.9-million free cash flow (FCF) recognition.

Yahoo | July 23, 2020

Core Lab Reports Second Quarter 2020 Results From Continuing Operations:

AMSTERDAM, July 22, 2020 /PRNewswire/ -- Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") ("Core", "Core …

Benzinga | July 22, 2020

Read More 'CLB' Stories Here

CLB Price Returns

1-mo 66.71%
3-mo 15.17%
6-mo 14.08%
1-year -44.55%
3-year -74.45%
5-year -77.24%
YTD -35.53%
2019 -34.35%
2018 -44.49%
2017 -6.83%
2016 12.57%
2015 -7.83%

CLB Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full CLB Dividend History

Continue Researching CLB

Want to see what other sources are saying about Core Laboratories N V's financials and stock price? Try the links below:

Core Laboratories N V (CLB) Stock Price | Nasdaq
Core Laboratories N V (CLB) Stock Quote, History and News - Yahoo Finance
Core Laboratories N V (CLB) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.9075 seconds.